|
ZNHIT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.90489999999777E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.097800E-02 |
| Normal-vs-Stage2 |
4.337800E-02 |
| Normal-vs-Stage3 |
2.035300E-04 |
| Normal-vs-Stage4 |
1.08369999995972E-06 |
| Stage1-vs-Stage2 |
1.745220E-01 |
| Stage1-vs-Stage3 |
2.545700E-02 |
| Stage1-vs-Stage4 |
2.40529999999683E-05 |
| Stage2-vs-Stage3 |
7.919000E-01 |
| Stage2-vs-Stage4 |
2.903000E-01 |
| Stage3-vs-Stage4 |
3.658400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.798300E-04 |
| Normal-vs-AfricanAmerican |
1.400330E-03 |
| Normal-vs-Asian |
2.752000E-01 |
| Caucasian-vs-AfricanAmerican |
7.733600E-02 |
| Caucasian-vs-Asian |
4.236400E-01 |
| AfricanAmerican-vs-Asian |
6.533400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.03879999999268E-05 |
| Normal-vs-Female |
2.348100E-02 |
| Male-vs-Female |
4.633800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.690460E-02 |
| Normal-vs-Age(41-60Yrs) |
9.560500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.400800E-03 |
| Normal-vs-Age(81-100Yrs) |
5.210300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.845000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.915000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.680200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.473600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.823000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.440400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.802200E-01 |
| Normal-vs-Grade 2 |
1.086190E-01 |
| Normal-vs-Grade 3 |
1.977260E-04 |
| Normal-vs-Grade 4 |
1.14179999999298E-06 |
| Grade 1-vs-Grade 2 |
8.054800E-01 |
| Grade 1-vs-Grade 3 |
1.379560E-01 |
| Grade 1-vs-Grade 4 |
2.542700E-03 |
| Grade 2-vs-Grade 3 |
3.521700E-02 |
| Grade 2-vs-Grade 4 |
3.6427000000061E-05 |
| Grade 3-vs-Grade 4 |
7.357800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.286600E-01 |
| Normal-vs-ccB subtype |
4.220600E-04 |
| ccA subtype-vs-ccB subtype |
3.87889999999835E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.600900E-03 |
| Normal-vs-N1 |
9.124300E-03 |
| N0-vs-N1 |
5.954200E-02 |
|
|
